The CD8+ cell non-cytotoxic antiviral response affects RNA polymerase II-mediated human immunodeficiency virus transcription in infected CD4+ cells

References

1. Barker E., Mackewicz C. E., Reyes-Terán G., Sato A., Stranford S. A., Fujimura S. H., Christopherson C., Chang S. Y., Levy J. A. 1998; Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome. Blood 92:3105–3114[PubMed]
   [Google Scholar]
2. Blazek D., Barboric M., Kohoutek J., Oven I., Peterlin B. M. 2005; Oligomerization of HEXIM1 via 7SK snRNA and coiled-coil region directs the inhibition of P-TEFb. Nucleic Acids Res 33:7000–7010 [View Article][PubMed]
   [Google Scholar]
3. Blazek D., Kohoutek J., Bartholomeeusen K., Johansen E., Hulinkova P., Luo Z., Cimermancic P., Ule J., Peterlin B. M. 2011; The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. Genes Dev 25:2158–2172 [View Article][PubMed]
   [Google Scholar]
4. Bonneau K. R., Ng S., Foster H., Choi K. B., Berkhout B., Rabson A., Mackewicz C. E., Levy J. A. 2008; Derivation of infectious HIV-1 molecular clones with LTR mutations: sensitivity to the CD8+ cell noncytotoxic anti-HIV response. Virology 373:30–38 [View Article][PubMed]
   [Google Scholar]
5. Brady J., Kashanchi F. 2005; Tat gets the green light on transcription initiation. Retrovirology 2:69 [View Article][PubMed]
   [Google Scholar]
6. Brinchmann J. E., Gaudernack G., Vartdal F. 1990; CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. Evidence for a soluble inhibitor. J Immunol 144:2961–2966[PubMed]
   [Google Scholar]
7. Chao S. H., Fujinaga K., Marion J. E., Taube R., Sausville E. A., Senderowicz A. M., Peterlin B. M., Price D. H. 2000; Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J Biol Chem 275:28345–28348 [View Article][PubMed]
   [Google Scholar]
8. Chen C. H., Weinhold K. J., Bartlett J. A., Bolognesi D. P., Greenberg M. L. 1993; CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. AIDS Res Hum Retroviruses 9:1079–1086 [View Article][PubMed]
   [Google Scholar]
9. Gómez A. M., Smaill F. M., Rosenthal K. L. 1994; Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease. Clin Exp Immunol 97:68–75 [View Article][PubMed]
   [Google Scholar]
10. Hoffman A. D., Banapour B., Levy J. A. 1985; Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 147:326–335 [View Article][PubMed]
    [Google Scholar]
11. Levy J. A. 1993; HIV pathogenesis and long-term survival. AIDS 7:1401–1410 [View Article][PubMed]
    [Google Scholar]
12. Levy J. A. 2003; The search for the CD8+ cell anti-HIV factor (CAF). Trends Immunol 24:628–632 [View Article][PubMed]
    [Google Scholar]
13. Levy J. A., Mackewicz C. E., Barker E. 1996; Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol Today 17:217–224 [View Article][PubMed]
    [Google Scholar]
14. Mackewicz C. E., Ortega H. W., Levy J. A. 1991; CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest 87:1462–1466 [View Article][PubMed]
    [Google Scholar]
15. Mackewicz C. E., Ortega H., Levy J. A. 1994; Effect of cytokines on HIV replication in CD4+ lymphocytes: lack of identity with the CD8+ cell antiviral factor. Cell Immunol 153:329–343 [View Article][PubMed]
    [Google Scholar]
16. Mackewicz C. E., Blackbourn D. J., Levy J. A. 1995; CD8+T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci U S A 92:2308–2312 [View Article][PubMed]
    [Google Scholar]
17. Mackewicz C. E., Patterson B. K., Lee S. A., Levy J. A. 2000; CD8+ cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration. J Gen Virol 81:1261–1264 [View Article][PubMed]
    [Google Scholar]
18. Ott M., Geyer M., Zhou Q. 2011; The control of HIV transcription: keeping RNA polymerase II on track. Cell Host Microbe 10:426–435 [View Article][PubMed]
    [Google Scholar]
19. Peterlin B. M., Price D. H. 2006; Controlling the elongation phase of transcription with P-TEFb. Mol Cell 23:297–305 [View Article][PubMed]
    [Google Scholar]
20. Raha T., Cheng S. W., Green M. R. 2005; HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs. PLoS Biol 3:e44 [View Article][PubMed]
    [Google Scholar]
21. Rahl P. B., Lin C. Y., Seila A. C., Flynn R. A., McCuine S., Burge C. B., Sharp P. A., Young R. A. 2010; c-Myc regulates transcriptional pause release. Cell 141:432–445 [View Article][PubMed]
    [Google Scholar]
22. Shridhar V., Chen Y., Gupta P. 2014; The CD8 antiviral factor (CAF) can suppress HIV-1 transcription from the long terminal repeat (LTR) promoter in the absence of elements upstream of the CATATAA box. Virol J 11:130 [View Article][PubMed]
    [Google Scholar]
23. Taube R., Lin X., Irwin D., Fujinaga K., Peterlin B. M. 2002; Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes. Mol Cell Biol 22:321–331 [View Article][PubMed]
    [Google Scholar]
24. Tomaras G. D., Lacey S. F., McDanal C. B., Ferrari G., Weinhold K. J., Greenberg M. L. 2000; CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression. Proc Natl Acad Sci U S A 97:3503–3508 [View Article][PubMed]
    [Google Scholar]
25. Walker C. M., Levy J. A. 1989; A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. Immunology 66:628–630[PubMed]
    [Google Scholar]
26. Walker C. M., Moody D. J., Stites D. P., Levy J. A. 1986; CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563–1566 [View Article][PubMed]
    [Google Scholar]